✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals
Market Cap
₹36,149 Cr.
P/E
49.00

Key Ratios

Market cap
Market cap
36,149 Cr
PE
PE
49.00
Prom Holding
Prom Holding
44.72 %
ROE (%)
ROE (%)
8.64
ROCE (%)
ROCE (%)
12.48
Div Yield (%)
Div Yield (%)
0.28
Sales
Sales
8,939 Cr
OPM (%)
OPM (%)
19.31 %
Debt to Equity
Debt to Equity
0.22
About
Established in 1949, IPCA Laboratories Limited is an integrated pharmaceutical company that ma… Read more
Low
1174
52W Range
High
1758
  • Ipca Laboratories
  • Ajanta Pharma
  • Gland Pharma
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
0.81 %
(as of Jul 22)
Anti - Diabetes - Market Share
1.03 %
(as of Jul 22)
Anti-Infectives - Market Share
55.08 %
(as of Nov 21)
Anti-Malarial - Market Share
3.84 %
(as of Nov 21)
Antineo Plastic - Market Share
0.11 %
(as of Nov 21)
Blood Related - Market Share
2.09 %
(as of Jul 22)
Cardiovascular - Market Share
Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up - Branded Generics

Location Wise Break-Up - Generics

Location Wise Break-Up - API

Location Wise Break-Up

Therapeutic Area Break-Up

Operational Metrics

    Select a Metric
    • Number of ANDA's Filed in USA (.)
    • Number of ANDA's Approved By USFDA (.)
    • Domestic Sales Growth - YoY (%)
    • US DMF Filings (.)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    Suppliers
    • Bharat Dynamics Ltd.
    • Elgi Equipments Ltd.
    • Borosil Renewables Ltd.
    • GMM Pfaudler Ltd.
    • Gulshan Polyols Ltd.
    FAQs on Ipca Laboratories Ltd. Business

    IPCA Laboratories Limited is a pharmaceutical company founded in 1949, with a global presence in manufacturing and marketing various formulations and APIs across different therapeutic segments. It is a leading supplier of APIs worldwide.

    Ipca Laboratories major competitors are Ajanta Pharma, Gland Pharma, Wockhardt, Pfizer, JB Chem & Pharma, Eris Lifesciences, Astrazeneca Pharma I.
    Market Cap of Ipca Laboratories is ₹36,149 Crs.
    While the median market cap of its peers are ₹26,469 Crs.

    Ipca Laboratories seems to be less financially stable compared to its competitors.
    Altman Z score of Ipca Laboratories is 6.6 and is ranked 6 out of its 8 competitors.

    Company Filing
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material